SARS-CoV-2 mRNA Vaccine Induces Robust Specific and Cross-reactive IgG and Unequal Strain-specific Neutralizing Antibodies in Naïve and Previously Infected Recipients
T. M. Narowski, K. Raphel, L. E. Adams, J. Huang, N. A. Vielot, R. Jadi, A. M. de Silva, R. S. Baric, J. E. Lafleur, L. Premkumar
This study examines antibody responses to SARS-CoV-2 mRNA vaccines in naive and previously infected individuals, finding robust IgG and varying neutralizing antibody levels against different variants.
bioRxiv · Jun 19, 2021Immunology